Muscular Atrophy

The supplied grounding identifies aging, reduced blood supply, immobilization, prolonged weightlessness, malnutrition, and denervation as causes or triggers. Review material also links muscle wasting to thyroid dysfunction, sepsis-induced myopathy, and age-related sarcopenia as related clinical contexts. These sources support a multifactorial etiology rather than a single cause.

The central biological theme is an imbalance between muscle protein synthesis and protein degradation. Review abstracts describe involvement of IGF-1/Akt/mTOR signaling, FoxO-dependent ubiquitin-proteasome pathways, myostatin-Smad signaling, inflammatory pathways, and autophagy-related mechanisms. Changes in satellite cell activity, proteostasis, mitochondrial function, and neuromuscular drive are also described in the literature.

Aging is a major risk factor, and the grounding also supports immobilization, prolonged weightlessness, malnutrition, denervation, and reduced blood supply. Related literature additionally associates muscle wasting with thyroid dysfunction and sepsis. Sarcopenia is described as an age-related syndrome with higher risk of falls, fractures, metabolic disease, and mortality, but those are consequences rather than primary risk factors.

The grounding does not support a single established standard treatment for muscular atrophy. The literature emphasizes prevention and modulation of underlying pathways, with drug-therapy discussions centered on anabolic or anti-catabolic signaling such as IGF-1-related pathways, myostatin inhibition, and GLP-1 receptor agonists in sepsis-induced muscle atrophy. At the modality level, strength exercise and contractile activity are described as stimuli that can promote muscle hypertrophy rather than atrophy.